Olema Pharmaceuticals, Inc.
OLMA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $839 | $364 | $321 | $342 |
| - Cash | $35 | $52 | $51 | $139 |
| + Debt | $1 | $2 | $1 | $1 |
| Enterprise Value | $806 | $314 | $272 | $204 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$42 | -$48 | -$35 | -$37 |
| % Margin | – | – | – | – |
| Net Income | -$42 | -$44 | -$30 | -$34 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.49 | -0.51 | -0.36 | -0.57 |
| % Growth | 3.9% | -41.7% | 36.8% | – |
| Operating Cash Flow | -$35 | -$30 | -$44 | -$26 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$35 | -$30 | -$44 | -$26 |